Christopher Posner, President and CEO at Cara Therapeutics, Inc. (CARA), sold 11,974 shares at $9.71 ($116K) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Open-market sale of $116k CARA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.71 | 5,987 | $58K | 50.0% |
| 2 | $9.71 | 5,987 | $58K | 50.0% |
| Total | $9.71 avg | 11,974 | $116K | 100% |
| Filing → |
| CARA | SELL | 2024-11-06 | $1K | — | Filing → |
| CARA | SELL | 2024-08-02 | $1K | — | Filing → |
| CARA | SELL | 2024-05-06 | $3K | — | Filing → |